Breast cancer treatment is based on the individual tumor’s expression of specific markers as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER) 2,the proliferation marker Ki-67, and the extent of the disease. Here, ESR1 is linked to neoplasm.